Mark J. Murray
Directeur/Bestuurslid bij Genevant Sciences Corp.
Actieve functies van Mark J. Murray
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Directeur/Bestuurslid | - | - |
Loopbaan van Mark J. Murray
Eerdere bekende functies van Mark J. Murray
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ARBUTUS BIOPHARMA CORPORATION | Directeur/Bestuurslid | 14-10-2011 | 24-06-2019 |
Algemeen Directeur | 30-05-2008 | 24-06-2019 | |
President | 30-05-2008 | 24-06-2019 | |
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Algemeen Directeur | 01-09-2000 | 02-12-2008 |
Oprichter | 02-12-2008 | 02-12-2008 | |
President | - | 02-12-2008 |
Opleiding van Mark J. Murray
Oregon Health & Science University | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 3 |
Canada | 3 |
Operationeel
Director/Board Member | 2 |
Chief Executive Officer | 2 |
President | 2 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ARBUTUS BIOPHARMA CORPORATION | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Health Technology |
- Beurs
- Insiders
- Mark J. Murray
- Ervaring